Article Versions Notes

Abraham T, Armold M, McGovern C, Harms JF, Darok MC, Gigliotti C, Adair B, Gray JL, Kelly DF, Adair JH, et al. CCK Receptor Inhibition Reduces Pancreatic Tumor Fibrosis and Promotes Nanoparticle Delivery. Biomedicines. 2024; 12(5):1024. https://doi.org/10.3390/biomedicines12051024

Abraham, Thomas, Michael Armold, Christopher McGovern, John F. Harms, Matthew C. Darok, Christopher Gigliotti, Bernadette Adair, Jennifer L. Gray, Deborah F. Kelly, James H. Adair, and et al. 2024. "CCK Receptor Inhibition Reduces Pancreatic Tumor Fibrosis and Promotes Nanoparticle Delivery" Biomedicines 12, no. 5: 1024. https://doi.org/10.3390/biomedicines12051024

Abraham, T., Armold, M., McGovern, C., Harms, J. F., Darok, M. C., Gigliotti, C., Adair, B., Gray, J. L., Kelly, D. F., Adair, J. H., & Matters, G. L. (2024). CCK Receptor Inhibition Reduces Pancreatic Tumor Fibrosis and Promotes Nanoparticle Delivery. Biomedicines, 12(5), 1024. https://doi.org/10.3390/biomedicines12051024